2779. Early Administration of Ceftazidime-Avibactam for Carbapenem-Resistant Enterobacterales Is Associated with Improved Clinical Success

Abstract Background Carbapenem-resistant Enterobacterales (CRE) are a significant public health threat. Ceftazidime-avibactam (CZA) retains activity against most carbapenemase-producing CRE and demonstrates favorable health outcomes compared to historically best available therapy. While early initia...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Open forum infectious diseases 2023-11, Vol.10 (Supplement_2)
Hauptverfasser:	Coyne, Ashlan J Kunz, Lucas, Kristen, Shald, Elizabeth, Cabanilla, M Gabriela, Yost, Christine, VanDorf, Sydney, Slaton, Cara, Kufel, Wesley D, Truong, James, Andrade, Justin A, Cerenzio, John, Biagi, Mark, Todd, Michaela, White, Bryan, Sassine, Joseph, Hayes, Jillian E, Witucki, Paige, Orzol, Carolina, Eshaya, Mirna, Bleick, Callan, Caniff, Kaylee E, Veve, Michael P, Rybak, Michael J
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!